Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Prevalence of polycystic ovary syndrome in adolescents.

Christensen SB, Black MH, Smith N, Martinez MM, Jacobsen SJ, Porter AH, Koebnick C.

Fertil Steril. 2013 Aug;100(2):470-7. doi: 10.1016/j.fertnstert.2013.04.001. Epub 2013 Jun 5.

3.

Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome.

Rossi B, Sukalich S, Droz J, Griffin A, Cook S, Blumkin A, Guzick DS, Hoeger KM.

J Clin Endocrinol Metab. 2008 Dec;93(12):4780-6. doi: 10.1210/jc.2008-1198. Epub 2008 Sep 23.

4.

Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome.

Hart R, Doherty DA, Mori T, Huang RC, Norman RJ, Franks S, Sloboda D, Beilin L, Hickey M.

Fertil Steril. 2011 Jun;95(7):2347-53, 2353.e1. doi: 10.1016/j.fertnstert.2011.03.001. Epub 2011 Mar 29.

PMID:
21450287
5.

Association between polycystic ovarian syndrome, overweight, and metabolic syndrome in adolescents.

Rahmanpour H, Jamal L, Mousavinasab SN, Esmailzadeh A, Azarkhish K.

J Pediatr Adolesc Gynecol. 2012 Jun;25(3):208-12. doi: 10.1016/j.jpag.2012.02.004.

PMID:
22578482
6.

Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.

Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, Teede HJ.

Hum Reprod. 2013 Mar;28(3):777-84. doi: 10.1093/humrep/des463. Epub 2013 Jan 12.

PMID:
23315061
7.

Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008.

Okoroh EM, Hooper WC, Atrash HK, Yusuf HR, Boulet SL.

Am J Obstet Gynecol. 2012 Nov;207(5):377.e1-8. doi: 10.1016/j.ajog.2012.08.007. Epub 2012 Aug 10.

8.

PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.

Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC.

BJOG. 2006 Oct;113(10):1210-7.

9.

Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome.

Joham AE, Ranasinha S, Zoungas S, Moran L, Teede HJ.

J Clin Endocrinol Metab. 2014 Mar;99(3):E447-52. doi: 10.1210/jc.2013-2007. Epub 2013 Sep 30.

PMID:
24081730
10.

Impact of obesity on the risk for polycystic ovary syndrome.

Yildiz BO, Knochenhauer ES, Azziz R.

J Clin Endocrinol Metab. 2008 Jan;93(1):162-8. Epub 2007 Oct 9.

11.

Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome.

Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS.

J Clin Endocrinol Metab. 2006 Apr;91(4):1357-63. Epub 2006 Jan 24.

PMID:
16434451
12.

Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?

Daan NM, Louwers YV, Koster MP, Eijkemans MJ, de Rijke YB, Lentjes EW, Fauser BC, Laven JS.

Fertil Steril. 2014 Nov;102(5):1444-1451.e3. doi: 10.1016/j.fertnstert.2014.08.001. Epub 2014 Sep 16.

PMID:
25239303
13.

Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.

Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H.

Hum Reprod. 2012 Oct;27(10):3067-73. doi: 10.1093/humrep/des232. Epub 2012 Jul 9.

PMID:
22777527
14.

Fasting Glucose Changes in Adolescents with Polycystic Ovary Syndrome Compared with Obese Controls: A Retrospective Cohort Study.

Javed A, Lteif AN, Kumar S, Simmons PS, Chang AY.

J Pediatr Adolesc Gynecol. 2015 Dec;28(6):451-6. doi: 10.1016/j.jpag.2015.01.001. Epub 2015 Jan 7.

15.

Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.

West S, Lashen H, Bloigu A, Franks S, Puukka K, Ruokonen A, Järvelin MR, Tapanainen JS, Morin-Papunen L.

Hum Reprod. 2014 Oct 10;29(10):2339-51. doi: 10.1093/humrep/deu200. Epub 2014 Aug 1.

16.

Effect of body mass index on in vitro fertilization outcomes in women with polycystic ovary syndrome.

Bailey AP, Hawkins LK, Missmer SA, Correia KF, Yanushpolsky EH.

Am J Obstet Gynecol. 2014 Aug;211(2):163.e1-6. doi: 10.1016/j.ajog.2014.03.035. Epub 2014 Mar 18.

PMID:
24657792
17.

Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study.

Kyrkou G, Trakakis E, Attilakos A, Panagopoulos P, Chrelias C, Papadimitriou A, Vaggopoulos V, Alexiou E, Mastorakos G, Lykeridou A, Kassanos D, Papaevangelou V, Papantoniou N.

Arch Gynecol Obstet. 2016 Apr;293(4):915-23. doi: 10.1007/s00404-015-3964-y. Epub 2015 Nov 28.

PMID:
26615602
18.

Sleep disturbances in a community-based sample of women with polycystic ovary syndrome.

Moran LJ, March WA, Whitrow MJ, Giles LC, Davies MJ, Moore VM.

Hum Reprod. 2015 Feb;30(2):466-72. doi: 10.1093/humrep/deu318. Epub 2014 Nov 28.

PMID:
25432918
19.

Gonadal dysfunction in morbidly obese adolescent girls.

Chin V, Censani M, Lerner S, Conroy R, Oberfield S, McMahon D, Zitsman J, Fennoy I.

Fertil Steril. 2014 Apr;101(4):1142-8. doi: 10.1016/j.fertnstert.2013.12.046. Epub 2014 Feb 26.

20.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.

Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E; American Association of Clinical Endocrinologists (AACE).; American College of Endocrinology (ACE).; Androgen Excess and PCOS Society (AES)..

Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC.

PMID:
26509855

Supplemental Content

Support Center